Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Biosplice announces submission of new drug application to US FDA for treatment of knee osteoarthritis
Read More -
NEW YORK, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- ThinkLabs AI, a company specializing in AI-driven grid solutions, today announced results in collaboration with Southern California Edison (SCE)...
Read More
-
ITASCA, Ill., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Riverside Insights, a leading provider of trusted, research-backed assessments, today announced a new international distribution partnership with...
-
RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...
-
Vancouver, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce positive, consistent...
-
BitMart launches its Prediction Market, enabling USDT-based trading on crypto, sports, and event outcomes with real-time probability pricing.
-
The Evotrex-PG5 delivers advanced energy generation, intelligent power management, and a premium, durable design engineered to enable travelers to roam farther and stay longerThe RV trailer is on...
-
PyroGenesis Signs Agreement with U.S. Defense Contractor to Jointly Pursue Chemical Weapon Destruction Contracts in Syria.
-
RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 44th Annual J.P. Morgan...
-
SLINGERLANDS, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, announce its participation in...
-
Aarhus, Denmark, 6 January 2026 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, today...
-
Oxford, UK and Boston, MA – January 6, 2026 – Sitryx Therapeutics (“Sitryx” or “the Company”), a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in...